Daylife Select
A point & click tool to create dynamic content portals. Learn More »
There is no pinned content in this Editor's Picks module.
Click here to learn more about content pinning.
During these tough economic times for both patients and government agencies, I am delighted to announce this public-private collaboration between AstraZeneca and the City of Philadelphia to bring free medications to those most in need, who use our health centers
I am glad to see companies like AstraZeneca stepping up to support important health needs of Philadelphians. This program will make care at our centers more comprehensive and helps make the city a healthier place to live
PARP inhibitors, which include Sanofi-Aventis's BSI-201 and AstraZeneca's olaparib, could dramatically improve prognoses for the woefully underserved patient subgroups with DNA-repair-deficient tumors
AstraZeneca is proud to continue its longstanding support of the gastroenterology community by helping bring ACG members together in this unique and creative way
At Mercy Primary Care, we strive to eliminate the common barriers to quality care that many uninsured individuals face, and the AZ&Me(TM) program for healthcare facilities will help us work toward this goal ... In this challenging economic climate, our partnership with AstraZeneca will allow us to help ...
AstraZeneca recognizes that providing affordable and accessible healthcare to uninsured and underinsured Americans is critical to building healthy communities
The decision of the Supreme Court of Alabama confirms AstraZeneca's long standing position that the state's claims against the company are unfounded
The decision of the Supreme Court of Alabama confirms AstraZeneca’s longstanding position that the state’s claims against the company are unfounded
AstraZeneca is committed to studying the impact of CRESTOR in various populations with a high unmet medical need, including pediatric and adolescent patients. Information about the effects of CRESTOR in pediatric patients with HeFH will now be included in the CRESTOR Prescribing Information
The European Commission decision marks an important milestone in the alliance between Bristol-Myers Squibb and AstraZeneca. Our legacy in treating type 2 diabetes and cardiovascular disease, together with our knowledge and expertise, enables us to deliver to patients a medicine that will offer further c...
Diabetes is a growing epidemic currently affecting some 53 million people in Europe with the number of cases expected to increase. Today’s announcement is good news for those affected by type 2 diabetes and further demonstrates the commitment of AstraZeneca and Bristol-Myers Squibb to bring much needed ...
AstraZeneca is committed to providing physicians with accurate information about its medications and the illnesses they are approved to treat ... One of the ways AstraZeneca provides that information is through a speakers program in which recognized medical experts present information on the relevant il...
AstraZeneca is committed to providing physicians with accurate information about its medications and the illnesses they are approved to treat ... One of the ways AstraZeneca provides that information is through a speakers program in which recognized medical experts present information on the relevant il...
This partnership with UCB will leverage AstraZeneca's expertise in regulatory affairs, sales and marketing to help bring the benefits of Cimzia® to patients in Brazil
We expected AstraZeneca to appeal Judge Saris' ruling and are very pleased that the First Circuit saw the logic and solid thinking in the trial judge's well-reasoned ruling ... We believe that consumers and insurers across the country fell victim to this pricing scheme and believe our national action wi...
By aligning ourselves with SAFE-BioPharma, an integral industry association led by major pharmaceutical companies such as Pfizer, Eli Lilly and AstraZeneca, Symyx continues to ensure that sensitive intellectual property is securely captured and managed in the way our customers expect
There are no results for this module. Edit this module to change the search term used to query Wikipedia
David Brennan, Chief Executive Officer of drug maker AstraZeneca leaves the Marriot hotel in London after its Annual General Meeting, Thursday, April 30, 2009. AstraZeneca Thursday have posted a 42 percent rise in first quarter net profit.
View Photo »FILE - In this Jan. 29, 2009 file photo, reflections are seen on a sign outside the global headquarters of AstraZeneca in London.
View Photo »FILE -- In a Jan. 29, 2009 file photo reflections are seen in the sign on the global headquarters of AstraZeneca in London.
View Photo »Reflections are seen in the sign on the global headquarters of Astra Zeneca in London, Thursday, Jan. 29, 2009.
View Photo »FILE - In this Jan. 29, 2009 file photo, reflections are seen on a sign outside the global headquarters of AstraZeneca in London.
View Photo »During these tough economic times for both patients and government agencies, I am delighted to announce this public-private collaboration between AstraZeneca and the City of Philadelphia to bring free medications to those most in need, who use our health centers
I am glad to see companies like AstraZeneca stepping up to support important health needs of Philadelphians. This program will make care at our centers more comprehensive and helps make the city a healthier place to live
PARP inhibitors, which include Sanofi-Aventis's BSI-201 and AstraZeneca's olaparib, could dramatically improve prognoses for the woefully underserved patient subgroups with DNA-repair-deficient tumors
AstraZeneca is proud to continue its longstanding support of the gastroenterology community by helping bring ACG members together in this unique and creative way
At Mercy Primary Care, we strive to eliminate the common barriers to quality care that many uninsured individuals face, and the AZ&Me(TM) program for healthcare facilities will help us work toward this goal ... In this challenging economic climate, our partnership with AstraZeneca will allow us to help ...
AstraZeneca recognizes that providing affordable and accessible healthcare to uninsured and underinsured Americans is critical to building healthy communities
The decision of the Supreme Court of Alabama confirms AstraZeneca's long standing position that the state's claims against the company are unfounded
The decision of the Supreme Court of Alabama confirms AstraZeneca’s longstanding position that the state’s claims against the company are unfounded
AstraZeneca is committed to studying the impact of CRESTOR in various populations with a high unmet medical need, including pediatric and adolescent patients. Information about the effects of CRESTOR in pediatric patients with HeFH will now be included in the CRESTOR Prescribing Information
The European Commission decision marks an important milestone in the alliance between Bristol-Myers Squibb and AstraZeneca. Our legacy in treating type 2 diabetes and cardiovascular disease, together with our knowledge and expertise, enables us to deliver to patients a medicine that will offer further c...
Diabetes is a growing epidemic currently affecting some 53 million people in Europe with the number of cases expected to increase. Today’s announcement is good news for those affected by type 2 diabetes and further demonstrates the commitment of AstraZeneca and Bristol-Myers Squibb to bring much needed ...
AstraZeneca is committed to providing physicians with accurate information about its medications and the illnesses they are approved to treat ... One of the ways AstraZeneca provides that information is through a speakers program in which recognized medical experts present information on the relevant il...
AstraZeneca is committed to providing physicians with accurate information about its medications and the illnesses they are approved to treat ... One of the ways AstraZeneca provides that information is through a speakers program in which recognized medical experts present information on the relevant il...
This partnership with UCB will leverage AstraZeneca's expertise in regulatory affairs, sales and marketing to help bring the benefits of Cimzia® to patients in Brazil
We expected AstraZeneca to appeal Judge Saris' ruling and are very pleased that the First Circuit saw the logic and solid thinking in the trial judge's well-reasoned ruling ... We believe that consumers and insurers across the country fell victim to this pricing scheme and believe our national action wi...
By aligning ourselves with SAFE-BioPharma, an integral industry association led by major pharmaceutical companies such as Pfizer, Eli Lilly and AstraZeneca, Symyx continues to ensure that sensitive intellectual property is securely captured and managed in the way our customers expect
There are no results for this module. Edit the module to change the search term used to query Twitter.
